Status:
ACTIVE_NOT_RECRUITING
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.
Detailed Description
Participation in this research study involves two research visits, at least one of which is at Children's Hospital Boston. The first visit lasts about 4-6 hours. On this visit, the child will work wit...
Eligibility Criteria
Inclusion
- Diagnosis of autism spectrum disorder or suspected diagnosis based on clinical genetic test results (e.g., variant diagnosed via chromosomal microarray)
- Age ≥ 18 months
Exclusion
- Presence of a metabolic disorder
- Acquired developmental disability (e.g., birth asphyxia, trauma-related injury, meningitis, etc.) or cerebral palsy
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2030
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00910559
Start Date
July 1 2008
End Date
February 1 2030
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115